- CDC LGBT Health | Get Healthy and Ready for the Year Ahead
- CDC Morbidity and Mortality Weekly Report (MMWR) Mpox Reports
- HIV.gov Blog Post: Addressing Mpox Holistically
- Fact Sheet: White House Mpox Response Team Announces New Plans to Support Large LGBTQI+ Events and Equity Interventions to Reach Communities at Highest Risk of Contracting the Virus - The White House
- Fact Sheet: U.S. Department of Health and Human Services Response to Mpox Outbreak
- Fact Sheet: White House Announces New Actions to Combat Mpox Outbreak - The White House
- CDC Mpox Website
- U.S. Mpox Outbreak 2022: Situation Summary
- Mpox Frequently Asked Questions
- Social Gatherings, Safer Sex, and Mpox
- Disinfecting Home and Other Non-Healthcare Settings
- CDC Health Alert Network Messages
Mpox and HIV
- HIV.gov Mpox and People with HIV
- Mpox and HIV FAQs
- Clinical Considerations for Treatment and Prophylaxis of Mpox Virus Infection in People with HIV
- Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV - Mpox Information Brief
- Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV
- CDC MMWR: Severe Mpox in Hospitalized Patients – United States, August 10-October 10, 2022
- U.S. Department of Housing and Urban Development, Housing Opportunities for Persons with AIDS (HOPWA): In Focus - MMWR Severe Mpox Study (PDF - 297 KB)
Health care professionals and health departments
Mpox testing, treatment, and vaccination
- Testing Patients for Mpox (PDF)
- Preparation and Collection of Specimens
- Interim Clinical Guidance for the Treatment of Mpox
- Information for Healthcare Providers on Obtaining and Using TPOXX (Tecovirimat) for Treatment of Mpox
- FDA: Emergency Use Authorization Fact Sheet
- Considerations for Mpox Vaccination
- Vaccine Administration Errors and Deviations
- How to Administer the JYNNEOS Vaccine Intradermally
- ASPR: JYNNEOS Mpox Vaccine Distribution by Jurisdiction
- ASPR: Operational Planning Guide